What is the difference between CJC-1295 with and without DAC?

Without DAC (also called Modified GRF 1-29): half-life ~30 minutes, preserves pulsatile GH release, requires 2-3 daily injections. With DAC: half-life ~8 days, produces sustained non-pulsatile GH elevation, requires only weekly injections. Most users prefer without DAC for more physiological GH patterns.

Why do many users prefer CJC-1295 without DAC?

The non-DAC version maintains pulsatile GH release (mimicking natural physiology), has a shorter side effect window if problems arise, and is easier to dose-adjust. The DAC version cannot be quickly cleared if adverse effects occur.

Can CJC-1295 DAC be stacked with GHRP?

It can be, but the sustained GH elevation from DAC may make GHRP stacking less necessary. Many protocols use CJC-1295 without DAC + ipamorelin for synergistic pulsatile release instead.

What is the recommended dose range for CJC-1295 with DAC?

The research dose range is 1-2 mg per injection, administered via Subcutaneous injection, 1-2x per week.

peptide dosing

CJC-1295 with DAC Dosing & Reconstitution Guide

Complete dosing reference for CJC-1295 with DAC (Growth Hormone). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Subcutaneous injection Frequency: 1-2x per week Dose Range: 1-2 mg per injection

Safety & Contraindications

Safety: Water retention and edema reported, particularly facial puffiness Numbness and tingling in extremities Joint pain consistent with GH elevation

Contraindications: Active cancer or history of cancer (GH promotes cell proliferation); Diabetic retinopathy; Active pituitary tumors

Related Products

In Stock

CJC-1295 DAC 5mg

5mg

Application formLyophilized powder

StorageRefrigerated

Purity98%

AppearanceLyophilized powder

$49 USD

Related Research News

Regulatory

CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide

CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.

May 12, 2026

Peptide Tools

Fasting & Peptide Timing OptimizerOptimize dosing around meals, fasting, sleep.

Half-Life PlotterVisualize concentration over time with accumulation and steady-state.

Stack Synergy CheckerAnalyze synergies and stacking patterns between peptide pairs.

Famous Stacks VisualizerExplore popular stacks with synergy diagrams and evidence ratings.

Frequently Asked Questions

Related Resources

CJC-1295 DAC 5mg Browse All Research Peptides

Explore More

CJC-1295 with DAC Dosing Guide Peptides for Growth Hormone Peptides for Body Composition

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.